Goldenrod Therapeutics, Inc.

Biotechnology company · Houston, Texas, United States

Goldenrod Therapeutics, Inc. is a biotechnology company headquartered in Houston, Texas, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $3.2 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Goldenrod Therapeutics at a glance

Typebiotechnology company

HeadquartersHouston, Texas, United States

Earliest incorporation on record2023

SEC CIK2127885

What does Goldenrod Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $3.2 million sold (2026).

Frequently asked questions about Goldenrod Therapeutics

Where is Goldenrod Therapeutics headquartered?

Goldenrod Therapeutics, Inc. is headquartered in Houston, Texas, United States.

What does Goldenrod Therapeutics do?

Goldenrod Therapeutics, Inc. is a biotechnology company.

When was Goldenrod Therapeutics founded?

The earliest incorporation on record for Goldenrod Therapeutics, Inc. is in 2023, according to public company registers.

Similar companies

Pulmotect, Inc.Houston, Texas, United States
Kiromic Biopharma, Inc.Houston, Texas, United States
March Biosciences, Inc.Houston, Texas, United States
Autoimmunity Biologic Solutions Inc.Houston, Texas, United States
Fannin Partners, LLCHouston, Texas, United States
Brevitest Technologies, Inc.Houston, Texas, United States
Pupil Bio, Inc.Houston, Texas, United States
Asylia Therapeutics, Inc.Houston, Texas, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences